AbbVie announces HUMIRA (adalimumab) global patent license with Momenta
Tuesday, November 06, 2018 DrugName : adalimumab AbbVie announced patent license agreements with Momenta over its proposed biosimilar adalimumab product. Under
Read More
Tuesday, November 06, 2018 DrugName : adalimumab AbbVie announced patent license agreements with Momenta over its proposed biosimilar adalimumab product. Under
Read MoreTuesday, November 06, 2018 Suven Life Sciences Ltd., announces that the grant of one (1) product patent from Israel (255994)
Read MoreMonday, November 05, 2018 ResApp Health Limited, a leading digital health company developing smartphone applications for the diagnosis and management
Read MoreMonday, November 05, 2018 OcuMedic, Inc., the developer of new, drug-eluting soft contact lenses and clear, corneal bandage technology,
Read MoreBy GlobeNewswire, October 31, 2018, 11:00:00 AM EDT Here is some deeprootsmag.org sample of viagra of the evidence: Enhanced levels of
Read More